Eradicating deadly staph using a new breed of antibiotics has revealed promising results in research released by QUT, to help overcome one of the biggest modern medical challenges.
The bacteria attach to medical devices including catheters, artificial joints, implants and patients’ burns and wounds, establishing bacterial biofilms, a leading cause of failing antibiotic therapies and chronic infections.
QUT researchers have developed hybrid antibiotics designed to penetrate the slimy shield protecting invasive golden staph (Staphylococcus aureus) infections.
Led by Associate Professor Makrina Totsika and PhD student Anthony Verderosa (pictured below), the research has been published in top infectious diseases journal Antimicrobial Agents and Chemotherapy.
The study found hybrid antibiotics worked well by destroying Staph biofilms grown in the lab.
“Biofilms are a sticky, slimy coating that often prevents conventional antibiotics from accessing bacterial cells,” Mr Verderosa said.
“We have developed a new breed of antibiotic that tricks biofilms into releasing their protected cells allowing access through the protective slimy coating of the biofilm.
“This allows for the biofilms to be eradicated.”
He said the microscopic compound emits a fluorescence signal enabling researchers to watch the drug penetrating the biofilm, either killing the bacteria directly or leaving them susceptible to killing.
Associate Professor Totsika said the majority of infections, even those not associated with an implanted medical device, involve biofilms in some way so the potential for these drugs is wide.
“We are now gearing up to do pre-clinical testing,” she said.
“What is promising is the fact that our compounds are hybrids of drugs that are already in clinical use as stand-alone therapies, such as conventional antibiotics and nitroxides, so this offers hope that they could be translated into clinical therapies in the not so distant future.”
Hospital acquired infections and increasing resistance to antibiotics has challenged medical researchers to find and test novel antimicrobial agents, including alternatives to antibiotics.
The World Health Organisation has identified antibiotic resistant pathogens as one of the “biggest threats to global health today”.
Associate Professor Totsika said there was scope to apply the research beyond medicine, to agriculture, biotechnology and other industries.
Go deeper with Bing News on:
- Will genetic modification help control mosquitoes — or just create different ones?on May 8, 2020 at 10:18 am
The EPA has approved testing the new insects in the Florida Keys, stinging some who fought the trial for years ...
- Vystar Resumes Production of FDA Certified Rx3000 UV Light Air Purifiers for Use in Healthcare Facilitieson May 7, 2020 at 6:13 am
Rx3000® UV Light Air Purifier production shifts to Massachusetts to ensure quality, fast production & deliveryRx3000 inactivates on first ...
- Best Infection Prevention Productson May 6, 2020 at 4:00 am
During the coronavirus outbreak, health care is more important than ever. In Newsweek's first Best Health Care series, we highlight the best infection prevention products.
- Rapid identification of pathogens, antibiotic resistance genes and plasmids in blood cultures by nanopore sequencingon May 6, 2020 at 2:10 am
Most studies on sepsis and BSIs report an increasing incidence over the last two decades 3, particularly among the immunocompromised, multimorbid, and elderly patients, or due to failure of empiric ...
- Europe Antibiotics Market 2020 is Evolving Rapidly with Economic Growth, Demand, and Forthcoming Opportunitieson April 30, 2020 at 1:47 am
The leading manufacturers of Antibiotics are currently implementing technologically advanced production processes to increase production efficacy and optimize product offerings. The current ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Infection Risk No Higher With Recycled Pacemakers, Defibrillatorson May 7, 2020 at 12:54 pm
The results, say researchers, will hopefully lead to more centers reusing devices for patients in countries with fewer resources.
- Ceftaroline Fosamil Market Industry – Growth, Trends, and Forecast (2020 – 2025)on May 7, 2020 at 4:59 am
Market Research Engine has published a new report titled as "Ceftaroline Fosamil Market Size By Type (Intravenous Therapy, Oral Type), By Application (Drug-resistant staphylococcus aureus infection, ...
- Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market to surpass US$ 211.3 Mn globally by 2027, Says CMIon April 30, 2020 at 5:33 am
The global methicillin resistant staphylococcus aureus (MRSA) testing systems market is expected to witness significant growth owing to product launches by market players. For instance, in June 2017, ...
- Guava: The super fruit that may help us fight COVID-19 infectionon April 27, 2020 at 11:04 am
Apart from all these, scientists have now found a new piece of information about this fruit which may be a new ray of hope amidst the COVID-19 pandemic. According to them, certain components of guava ...
- Tick protein joins fight against MRSAon April 25, 2020 at 5:00 pm
Using the protein in combination with existing treatments might help address the growing challenge of MRSA and other staph infections, researchers say. Resistance to antibiotic treatment is a ...